產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務(wù)熱線
產(chǎn)品概述
McCoy's 5A培養(yǎng)基是Thomas McCoy等人在1959年設(shè)計的培養(yǎng)基，最初專門用于Novikoff Hepatoma細胞的培養(yǎng)。McCoy's 5A培養(yǎng)基是改良的Basal Medium 5A，與其他培養(yǎng)基不同的是，McCoy's 5A含有還原型谷胱甘肽、細菌蛋白胨以及高濃度的葡萄糖。McCoy's 5A廣泛用于多種類型的原代細胞的培養(yǎng)，如骨髓、皮膚、牙齦、腎、脾、肺、大鼠胚胎、網(wǎng)膜等。此外McCoy's 5A培養(yǎng)基還用于組織活檢培養(yǎng)、細胞建系，以及一些淋巴細胞和較難培養(yǎng)的細胞的培養(yǎng)。
本產(chǎn)品含有多類細胞培養(yǎng)所需的氨基酸、維生素、無機鹽等多種成分，但不含蛋白質(zhì)、脂類或任何生長因子，故此產(chǎn)品需搭配血清或無血清添加物使用。
成分說明
形態(tài) | 液體 |
濃度 | 1× |
規(guī)格 | 500mL |
PH | 7.2～7.4 |
L-谷氨酰胺 | 1.5mM |
NaHCO3 | 2200mg/L |
D-葡萄糖 | 3000mg/L |
HEPES緩沖劑 | 無 |
酚紅指示劑 | 10mg/L |
儲存條件 | 2～8℃，避光 |
運輸條件 | 常溫 |
有效期 | 18個月 |
注意事項
1、本產(chǎn)品經(jīng)過濾除菌，使用時應(yīng)注意無菌操作，避免污染；
2、為保持本產(chǎn)品的最佳使用效果，請勿進行凍融處理；
3、本產(chǎn)品僅用于科研或進一步研究使用，不用于診斷和治療。
參考文獻
-
Epi-Endocytic Performance Engineering through Nanomaterials Co-Challenging: A Study of Mechanism and Implication in Radiotherapy(2024/05/01)
作者：Huiyue Zhao, Liuting Zheng, Ruxuan Ma
期刊：ADVANCED FUNCTIONAL MATERIALS
影響因子 ：19.000
引用產(chǎn)品：PM150710
-
Nitroreductase-instructed supramolecular assemblies for microbiome regulation to enhance colorectal cancer treatments(2022/11/09)
作者：Jiali Chen, Pai Zhang, Yan Zhao, Jie Zhao, Xiaobo Wu, Ruijia Zhang, Ruitao Cha, Qingxin Yao, Yuan Gao
期刊：Science Advances
影響因子 ：13.600
引用產(chǎn)品：CL-0071 CL-0096 CL-0101 CL-0118 PM150110 PM150210 PM150710
-
Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer(2024/02/26)
作者：Weisong Li, Kai Zhang, Wenjun Wang
期刊：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
DOI：10.1186/s13046-024-02981-5
影響因子 ：11.300
引用產(chǎn)品：PM150710
-
Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization(2024/02/14)
作者：Hanchu Xiong, Yanan Zhai, Yimei Meng
期刊：CANCER LETTERS
DOI：10.1016/j.canlet.2024.216732
影響因子 ：9.700
引用產(chǎn)品：PM150710
-
WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity(2023/01/07)
作者：Xiaosong Wei, Beibei Wang, Zixin Wu
期刊：CANCER LETTERS
DOI：10.1016/j.canlet.2023.216058
影響因子 ：9.700
引用產(chǎn)品：CL-0002 CL-0125 CL-0222 CL-0227 CL-0463 CL-0628 PM150410 PM150710 PM150910 PM151010
-
Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis(2023/02/14)
作者：Fuli Shi, Lisha Yuan, Taksui Wong
期刊：PHARMACOLOGICAL RESEARCH
DOI：10.1016/j.phrs.2023.106697
影響因子 ：9.300
引用產(chǎn)品：PM150710
-
Regulation of ULK1 by WTAP/IGF2BP3 axis enhances mitophagy and progression in epithelial ovarian cancer(2024/01/29)
作者：Jiao Wang, Fei Zheng, Dandan Wang
期刊：Cell Death & Disease
DOI：10.1038/s41419-024-06477-0
影響因子 ：9.000
引用產(chǎn)品：PM150710
-
TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3(2024/05/22)
作者：Qi Zhang, Yong Li, Qing Zhu
期刊：Cell Death & Disease
DOI：10.1038/s41419-024-06741-3
影響因子 ：9.000
引用產(chǎn)品：PM150710
-
A possible but unrecognized risk of acceptable daily intake dose triazole pesticides exposure—bile acid disturbance induced pharmacokinetic changes of oral medication(2023/02/21)
作者：Yujing Xu, Yufeng Zhang, Quan Tao
期刊：CHEMOSPHERE
DOI：10.1016/j.chemosphere.2023.138209
影響因子 ：8.800
-
Downregulation of TEX11 promotes S-Phase progression and proliferation in colorectal cancer cells through the FOXO3a/COP1/c-Jun/p21 axis(2022/10/18)
作者：Xiaodong Zhang, Fangyu Hu, Baiwang Zhu
期刊：ONCOGENE
DOI：10.1038/s41388-022-02490-9
影響因子 ：8.756
引用產(chǎn)品：PM150710
-
Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3(2022/09/24)
作者：Tianyi Shen, Suqin Miao, Yulin Zhou
期刊：Cell Communication and Signaling
DOI：10.1186/s12964-022-00957-6
影響因子 ：8.400
引用產(chǎn)品：PM150710
-
High-content image screening to identify chemical modulators for peroxisome and ferroptosis(2024/02/17)
作者：Daheng Zheng, Fei Li, Shanshan Wang
期刊：CELLULAR & MOLECULAR BIOLOGY LETTERS
DOI：10.1186/s11658-024-00544-2
影響因子 ：8.300
引用產(chǎn)品：PM150710
-
Mutual regulation between TRIM21 and TRIM8 via K48-linked ubiquitination(2023/11/01)
作者：Lin Wang, Hui Li, Aixue Huang
期刊：ONCOGENE
DOI：10.1038/s41388-023-02879-0
影響因子 ：8.000
引用產(chǎn)品：PM150710
-
Formyl peptide receptor 1 mitigates colon inflammation and maintains mucosal homeostasis through the inhibition of CREB-C/EBPβ-S100a8 signaling(2024/04/15)
作者：Tingting Li, Xiaojun Zhou, Qian Zhang
期刊：Mucosal Immunology
DOI：10.1016/j.mucimm.2024.04.001
影響因子 ：8.000
引用產(chǎn)品：PM150710
-
GSK3β and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer(2024/04/25)
作者：Wulin Shan, Wenju Peng, Yao Chen
期刊：ONCOGENE
DOI：10.1038/s41388-024-03040-1
影響因子 ：8.000
引用產(chǎn)品：PM150710
-
Photothermal Nanoheaters-Modified Spores for Safe and Controllable Antitumor Therapy(2022/12/15)
作者：Xin Zhang, Yang Zhang, Ning Wang
期刊：International Journal of Nanomedicine
影響因子 ：8.000
引用產(chǎn)品：PM150710
-
Isothiocyanate Iberin inhibits cell proliferation and induces cell apoptosis in the progression of ovarian cancer by mediating ROS accumulation and GPX1 expression(2021/06/17)
作者：Tingting Gong, Qian Guo, Xiao Li
期刊：Biomedicine & Pharmacotherapy
DOI：10.1016/j.biopha.2021.111533
影響因子 ：7.500
-
Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action(2022/10/31)
作者：Zukela Ruzi, Khurshed Bozorov, Lifei Nie
期刊：BIOMEDICINE & PHARMACOTHERAPY
DOI：10.1016/j.biopha.2022.113948
影響因子 ：7.500
引用產(chǎn)品：PM150710
-
Chiral Analysis of Lactate during Direct Contact Coculture by Single-Cell On-Probe Enzymatic Dehydrogenation Derivatization: Unraveling Metabolic Changes Caused by d-Lactate(2021/03/16)
作者：Yuling Li, Bowen Zhou, Yuqi Cao
期刊：Analytical Chemistry
DOI：10.1021/acs.analchem.0c05015
影響因子 ：7.400
-
Aa-Z2 triggers ROS-induced apoptosis of osteosarcoma by targeting PDK-1(2023/01/07)
作者：Yixin Liu, Wenyan She, Yi Li
期刊：Journal of Translational Medicine
DOI：10.1186/s12967-022-03862-1
影響因子 ：7.400
-
Combined Molecular and Morphological Imaging of CTCs for HER2-Targeted Chemotherapy Guidance(2023/08/22)
作者：Haimeng Pei, Zhaojun Han, Dexin Du
期刊：ANALYTICAL CHEMISTRY
DOI：10.1021/acs.analchem.3c02333
影響因子 ：7.400
-
Chlorophyllin Inhibits Mammalian Thioredoxin Reductase 1 and Triggers Cancer Cell Death(2021/10/29)
作者：Shibo Sun, Yici Zhang, Weiping Xu
期刊：Antioxidants
影響因子 ：7.000
-
NREP, transcriptionally upregulated by HIF-1α, aggravates breast cancer cell growth and metastasis by promoting glycolysis(2024/05/02)
作者：Yuxia Ruan, Jianghua Qiao, Jiabin Wang
期刊：Cell Death Discovery
DOI：10.1038/s41420-024-01951-2
影響因子 ：7.000
引用產(chǎn)品：PM150710
-
Preparation and biological evaluation of antibody targeted metal-organic framework drug delivery system (TDDS) in Her2 receptor-positive cells(2023/11/13)
作者：Chen Qing, Xiaonan Zhang, Guoyu Ding
期刊：TALANTA
DOI：10.1016/j.talanta.2023.125380
影響因子 ：6.100
引用產(chǎn)品：PM150710
-
High-fat diet alters the radiation tolerance of female mice and the modulatory effect of melatonin(2023/06/19)
作者：Lu Lu, Jinming Ren, Tong Yuan
期刊：Food & Function
影響因子 ：6.100
引用產(chǎn)品：PM150710
-
Multi-omics analysis reveals the unique landscape of DLD in the breast cancer tumor microenvironment and its implications for immune-related prognosis(2024/03/06)
作者：Lijun Xu, Lei Yang, Dan Zhang
期刊：Computational and Structural Biotechnology Journal
DOI：10.1016/j.csbj.2024.02.016
影響因子 ：6.000
引用產(chǎn)品：PM150710
-
Identification of a novel pyridine derivative with inhibitory activity against ovarian cancer progression in vivo and in vitro(2022/11/18)
作者：Lulu Si, Tianjiao Lai, Junru Zhao
期刊：Frontiers in Pharmacology
DOI：10.3389/fphar.2022.1064485
影響因子 ：5.988
引用產(chǎn)品：PM150710
-
ADAM10 promotes cell growth, migration, and invasion in osteosarcoma via regulating E-cadherin/β-catenin signaling pathway and is regulated by miR-122-5p(2020/03/30)
作者：Quan Yuan, Honghao Yu, Jianhua Chen
期刊：Cancer Cell International
DOI：10.1186/s12935-020-01174-2
影響因子 ：5.800
-
What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance(2024/01/13)
作者：Jin Qi, Sihang Liu, Zhirui Zhang
期刊：Cancer Cell International
DOI：10.1186/s12935-024-03216-5
影響因子 ：5.800
引用產(chǎn)品：PM150710
-
A1BG-AS1 promotes the biological functions of osteosarcoma cells via regulating the microRNA-148a-3p/USP22 axis and stabilizing the expression of SIRT1 through deubiquitinase function(2023/10/03)
作者：Xiuxin Han, Mengfan Yin, Chen Gong
期刊：EXPERT OPINION ON THERAPEUTIC TARGETS
DOI：10.1080/14728222.2023.2263908
影響因子 ：5.800
引用產(chǎn)品：PM150710
-
Nigericin exerts anticancer effects through inhibition of the SRC/STAT3/BCL-2 in osteosarcoma(2022/01/31)
作者：Zhiqiang Yang, Jiangtao Xie, Jiayu Fang
期刊：Biochemical Pharmacology
影響因子 ：5.800
引用產(chǎn)品：PM150710
-
A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma(2022/12/01)
作者：Lina Zhang, Song Wu, Junjie Huang
期刊：Frontiers in Oncology
影響因子 ：5.738
引用產(chǎn)品：PM150710
-
Itraconazole inhibits tumor growth via CEBPB-mediated glycolysis in colorectal cancer(2024/01/26)
作者：Yong Zhang, Lu Li, Feifei Chu
期刊：CANCER SCIENCE
影響因子 ：5.700
引用產(chǎn)品：PM150710
-
Celastrol inhibits necroptosis by attenuating the RIPK1/RIPK3/MLKL pathway and confers protection against acute pancreatitis in mice(2023/03/08)
作者：Qiqi Liang, Zijian Shi, Tao Yuan
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2023.109974
影響因子 ：5.600
引用產(chǎn)品：PM150710
-
Lycium barbarum Polysaccharide Reverses Drug Resistance in Oxaliplatin-Resistant Colon Cancer Cells by Inhibiting PI3K/AKT-Dependent Phosphomannose Isomerase(2024/03/01)
作者：LIjun Ma, Fangfang Ai, Yongzhao Zhu
期刊：Frontiers in Pharmacology
DOI：10.3389/fphar.2024.1367747
影響因子 ：5.600
引用產(chǎn)品：PM150710
-
Gentianine alleviates dextran sulfate sodium-induced ulcerative colitis via inhibition of TLR4/NLRP3-mediated pyroptosis(2023/11/17)
作者：Yunxia Li, Lei Lv, Shaoliang Li
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2023.111214
影響因子 ：5.600
引用產(chǎn)品：PM150710
-
IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism(2023/04/23)
作者：Tianyue Liu, Chenchen Hu, Chenying Han
期刊：Biology Direct
DOI：10.1186/s13062-023-00373-x
影響因子 ：5.500
引用產(chǎn)品：PM150710
-
An investigation into the HIF-dependent intestinal barrier protective mechanism of Qingchang Wenzhong decoction in ulcerative colitis management(2024/01/26)
作者：Mengjuan Yang, Yinuo Zhang, Zhi Qiao
期刊：JOURNAL OF ETHNOPHARMACOLOGY
影響因子 ：5.400
引用產(chǎn)品：PM150710
-
Meroterpenoids from Marine Sponge Hyrtios sp. and Their Anticancer Activity against Human Colorectal Cancer Cells(2024/04/19)
作者：Jie Wang, Yuelu Yan, Xinyi Yu
期刊：Marine Drugs
影響因子 ：5.400
引用產(chǎn)品：PM150710
-
PYY modulates the tumorigenesis and progression of colorectal cancer unveiled by proteomics(2022/12/15)
作者：Fangyan Jing, Guanglong Liu, Renyi Zhang
期刊：American Journal of Cancer Research
DOI：PMID:36628274
影響因子 ：5.300
引用產(chǎn)品：PM150710
-
Targeted PLK1 suppression through RNA interference mediated by high-fidelity Cas13d mitigates osteosarcoma progression via TGF-β/Smad3 signalling(2024/05/23)
作者：Yi Yuan, Daigui Cao, Anwei Zhang
期刊：JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
影響因子 ：5.300
引用產(chǎn)品：PM150710
-
Comprehensive Pan-Cancer Analyses of Immunogenic Cell Death as a Biomarker in Predicting Prognosis and Therapeutic Response(2022/12/01)
作者：Yuan Wang, Yongbiao Huang, Mu Yang
期刊：Cancers
影響因子 ：5.200
引用產(chǎn)品：PM150710
-
Molecular characterization of ferroptosis in soft tissue sarcoma constructs a prognostic and immunotherapeutic signature through experimental and bioinformatics analyses.(2023/10/20)
作者：Zhiqiang Yang, Liangyu Guo, Kangwen Xiao
期刊：Aging-US
影響因子 ：5.200
引用產(chǎn)品：PM150710
-
NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression(2024/04/12)
作者：Zhipeng Zhang, Pengfei Wang, Siwen Chen
期刊：Aging-US
影響因子 ：5.200
引用產(chǎn)品：PM150710
-
Establishment of an immunogenic cell death-related model for prognostic prediction and identification of therapeutic targets in endometrial carcinoma(2024/03/08)
作者：Zhenran Liu, Yue Huang, Pin Zhang
期刊：Aging-US
影響因子 ：5.200
引用產(chǎn)品：PM150710
-
Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties(2023/04/03)
作者：Zukela Ruzi, Khurshed Bozorov, Lifei Nie
期刊：BIOORGANIC CHEMISTRY
DOI：10.1016/j.bioorg.2023.106506
影響因子 ：5.100
引用產(chǎn)品：PM150710
-
Synthesis and anticancer activity of ethyl 5-amino-1-N-substituted-imidazole-4-carboxylate building blocks(2021/05/25)
作者：Zukela Ruzi, Lifei Nie, Khurshed Bozorov
期刊：Archiv Der Pharmazie
影響因子 ：5.100
引用產(chǎn)品：PM150710
-
Anti-Necroptotic Effects of Itaconate and its Derivatives(2023/09/27)
作者：Sitao Ni, Qing Li, Ying Chen
期刊：INFLAMMATION
DOI：10.1007/s10753-023-01909-z
影響因子 ：5.100
引用產(chǎn)品：PM150710
-
CBLC promotes the development of colorectal cancer by promoting ABI1 degradation to activate the ERK signaling pathway(2024/05/13)
作者：Zhan Li, Guanyu Yan, Meiqi Yang
期刊：Translational Oncology
DOI：10.1016/j.tranon.2024.101992
影響因子 ：5.000
引用產(chǎn)品：PM150710
-
NPR3, transcriptionally regulated by POU2F1, inhibits osteosarcoma cell growth through blocking the PI3K/AKT pathway(2021/7/3)
作者：Shuo Li, Ruirong Guo, Zhibin Peng
期刊：Cellular Signalling
DOI：10.1016/j.cellsig.2021.110074
影響因子 ：4.800
引用產(chǎn)品：PM150710
-
LAMA5 promotes cell proliferation and migration in ovarian cancer by activating Notch signaling pathway(2023/08/01)
作者：Bowen Diao, Chongfeng Sun, Panpan Yu
期刊：FASEB JOURNAL
影響因子 ：4.800
引用產(chǎn)品：PM150710
-
LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1(2024/02/20)
作者：Xuehui Wang, Diya Liu, Kaiyao Hua
期刊：CELLULAR SIGNALLING
DOI：10.1016/j.cellsig.2024.111112
影響因子 ：4.800
引用產(chǎn)品：PM150710
-
Upregulated X-C motif chemokine ligand 2 (XCL2) is associated with poor prognosis and increased immune infiltration in clear cell renal cell carcinoma(2022/12/09)
作者：Qingqiong Cao, Daoquan Liu, Zhao Chen
期刊：CELLULAR SIGNALLING
DOI：10.1016/j.cellsig.2022.110556
影響因子 ：4.800
引用產(chǎn)品：PM150710
-
Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway(2021/06/18)
作者：Jiangtao Fan, Zhaoyu Zhou, Yanlu Luo
期刊：Neoplasia
影響因子 ：4.800
-
TFE3-SLC36A1 axis promotes resistance to glucose starvation in kidney cancer cells(2024/04/08)
作者：Suli Lv, Zongbiao Zhang, Zhenyong Li
期刊：JOURNAL OF BIOLOGICAL CHEMISTRY
影響因子 ：4.800
引用產(chǎn)品：PM150710
-
ARHGAP25 suppresses the development of breast cancer by an ARHGAP25/Wnt/ASCL2 feedback loop(2023/06/16)
作者：Sijia Han, Xueying Jin, Tianyu Hu
期刊：CARCINOGENESIS
影響因子 ：4.700
-
A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma.(2022/11/11)
作者：Xinxing Wang, Guang Xia, Shilang Xiao, Song Wu, Lina Zhang, Junjie Huang, Wenxiu Zhang, Xu Cao, Image_1.tif, Image_2.tif, Image_3.tif, Image_4.tif, Image_5.tif, Image_6.tif, Image_7.tif, DataSheet_1.csv, DataSheet_2.csv, DataSheet_3.csv, DataSheet_4.
期刊：Frontiers in Oncology
影響因子 ：4.700
-
Low ACADM expression predicts poor prognosis and suppressive tumor microenvironment in clear cell renal cell carcinoma(2024/04/25)
作者：Libin Zhou, Min Yin, Fei Guo
期刊：Scientific Reports
DOI：10.1038/s41598-024-59746-5
影響因子 ：4.600
引用產(chǎn)品：PM150710
-
MMP9 and TYROBP affect the survival of circulating tumor cells in clear cell renal cell carcinoma by adapting to tumor immune microenvironment(2023/04/28)
作者：Lingyu Guo, Tian An, Haibin Zhou
期刊：Scientific Reports
DOI：10.1038/s41598-023-34317-2
影響因子 ：4.600
引用產(chǎn)品：PM150710
-
A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma(2022/12/10)
作者：Kenan Zhang, Wuping Yang, Zedan Zhang
期刊：Journal of Oncology
影響因子 ：4.501
-
Up-Regulation of SH3TC2 Induced by YTHDF1 Predicts Poor Outcome and Facilitates Cell-Cycle Progress in Colorectal Cancer(2022/12/15)
作者：Huili Wu, Feifei Chu, Lu Li
期刊：Journal of Oncology
影響因子 ：4.501
-
WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner(2023/03/29)
作者：Qiyong Pan, Jigang Lou, Penghui Yan
期刊：ENVIRONMENTAL TOXICOLOGY
影響因子 ：4.500
引用產(chǎn)品：PM150710
-
Downregulation of circ-RAPGEF5 inhibits colorectal cancer progression by reducing the expression of polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3)(2024/05/22)
作者：Duo Cheng, Feifei Chu, Fang Liang
期刊：ENVIRONMENTAL TOXICOLOGY
影響因子 ：4.500
引用產(chǎn)品：PM150710
-
Fatty Acid–Binding Protein 4 (FABP4) Suppresses Proliferation and Migration of Endometrial Cancer Cells via PI3K/Akt Pathway(2021/06/29)
作者：Zimeng Wu, Ji-Hak Jeong, Chenchen Ren
期刊：OncoTargets and Therapy
影響因子 ：4.345
-
miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition(2022/10/31)
作者：Lianjie Lin, Dongxu Wang, Suxuan Qu
期刊：Drug Design Development and Therapy
影響因子 ：4.319
引用產(chǎn)品：PM150710
-
OSU-03012 Disrupts Akt Signaling and Prevents Endometrial Carcinoma Progression in vitro and in vivo(2021/04/30)
作者：Leilei Ding, Chenchen Ren, Li Yang
期刊：Drug Design Development and Therapy
影響因子 ：4.319
-
OSU-03012 Disrupts Akt Signaling and Prevents Endometrial Carcinoma Progression in vitro and in vivo(2022/09/30)
作者：Leilei Ding, Chenchen Ren, Li Yang
期刊：Drug Design Development and Therapy
影響因子 ：4.319
引用產(chǎn)品：PM150710
-
The induction of ferroptosis by KLF11/NCOA4 axis: the inhibitory role in clear cell renal cell carcinoma(2023/08/29)
作者：Ziqi Zhou, Xi Lv, Shibo Liu
期刊：Human Cell
DOI：10.1007/s13577-023-00973-9
影響因子 ：4.300
-
Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription(2022/08/14)
作者：Yu Zhong, Ouyang Ling
期刊：Human Cell
DOI：10.1007/s13577-022-00767-5
影響因子 ：4.300
引用產(chǎn)品：PM150710
-
Circ_0056618 enhances PRRG4 expression by competitively binding to miR-411-5p to promote the malignant progression of colorectal cancer(2022/08/02)
作者：Bo Zhang, Wenbin Cao, Yang Liu
期刊：MOLECULAR AND CELLULAR BIOCHEMISTRY
DOI：10.1007/s11010-022-04525-x
影響因子 ：4.300
引用產(chǎn)品：164210 164210-50 CL-0096 CL-0144 CL-0223 CL-0225 PM150710 PM151010
-
Long non?coding RNA BLACAT2/miR?378a?3p/YY1 feedback loop promotes the proliferation, migration and invasion of uterine corpus endometrial carcinoma(2023/04/13)
作者：Chen Zhang, Ruicong Wang, Mengyuan Li
期刊：ONCOLOGY REPORTS
影響因子 ：4.200
-
GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD?L1 expression via STAT1 signaling(2023/01/20)
作者：Shujiang Ye, Siyu Li, Lei Qin
期刊：ONCOLOGY REPORTS
影響因子 ：4.200
-
LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β?catenin pathway(2023/02/10)
作者：Sijia Han, Xueying Jin, Tianyu Hu, Feng Chi
期刊：ONCOLOGY REPORTS
影響因子 ：4.200
-
Long-Lasting Proteinaceous Nanoformulation for Tumor Imaging and Therapy(2022/08/24)
作者：Lai Zhao, Xinquan Gu, Fuquan Jiang
期刊：ACS Omega
影響因子 ：4.100
-
Design, synthesis and biological evaluation of rhein–piperazine–furanone hybrids as potential anticancer agents(2024/02/13)
作者：Yu He, Sisi Zhang, Mengxue Wei
期刊：RSC Medicinal Chemistry
影響因子 ：4.100
引用產(chǎn)品：PM150710
-
MiR-519d and miR-328-3p Combinatorially Suppress Breast Cancer Progression(2023/04/07)
作者：Haiming Ma, Tao Liu, Yanhua Xu
期刊：OncoTargets and Therapy
影響因子 ：4.000
引用產(chǎn)品：PM150710
-
Identification of an EMT-related gene-based prognostic signature in osteosarcoma(2023/04/27)
作者：Haoli Gong, Ye Tao, Sheng Xiao
期刊：Cancer Medicine
影響因子 ：4.000
-
Circular RNA circ_0007142 Facilitates Colorectal Cancer Progression by Modulating CDC25A Expression via miR-122-5p(2023/04/07)
作者：Wenzhe Yin, Jun Xu, Chao Li
期刊：OncoTargets and Therapy
影響因子 ：4.000
引用產(chǎn)品：PM150710
-
UBP43 promotes epithelial ovarian carcinogenesis via activation of β-catenin signaling pathway(2023/04/26)
作者：Hongyang Xie, Junyu Chen, Changyan Ma
期刊：CELL BIOLOGY INTERNATIONAL
影響因子 ：3.900
-
Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study(2023/01/09)
作者：Weibo Dai, Jing Yang, Xin Liu
期刊：BMC Complementary Medicine and Therapies
DOI：10.1186/s12906-022-03822-8
影響因子 ：3.900
引用產(chǎn)品：PM150710
-
Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy(2022/10/19)
作者：Yongbiao Huang, Yuan Wang, Duo Xu
期刊：Frontiers in Genetics
影響因子 ：3.700
引用產(chǎn)品：PM150710
-
The potential of Lycium barbarum miR166a in kidney cancer treatment(2022/12/28)
作者：Qiang Zhang, Zhiyuan Xie, Yan Li
期刊：EXPERIMENTAL CELL RESEARCH
DOI：10.1016/j.yexcr.2022.113455
影響因子 ：3.700
-
Disulfidptosis-related PABPC3 promotes tumor progression and inhibits immune activity in osteosarcoma(2023/12/07)
作者：Yangbo Cao, Song Wu, Yishan Gu
期刊：JOURNAL OF GENE MEDICINE
DOI：10.1002/jgm.3641
影響因子 ：3.500
引用產(chǎn)品：PM150710
-
Diverse cell death patterns-related signature for predicting prognosis and drug sensitivity of osteosarcoma patients(2023/10/20)
作者：Yanbin Shi, Song Wu, Xiaolin Zhang
期刊：JOURNAL OF GENE MEDICINE
DOI：10.1002/jgm.3613
影響因子 ：3.500
引用產(chǎn)品：PM150710
-
Inorganic arsenic exposure promotes malignant progression by HDAC6-mediated down-regulation of HTRA1(2023/03/01)
作者：Jiafeng Chen, Cece Lei, Daibang Nie
期刊：JOURNAL OF APPLIED TOXICOLOGY
DOI：10.1002/jat.4457
影響因子 ：3.300
-
Circular RNA pyridoxal kinase (circPDXK) involves in the progression of ovarian cancer and glycolysis via regulating miR-654-3p and hexokinase II(2022/12/06)
作者：Lijuan Hou, Wenwen Wang, Jianjun Zhai
期刊：Applied Biological Chemistry
DOI：10.1186/s13765-022-00747-1
影響因子 ：3.200
引用產(chǎn)品：PM150710
-
DANCR maintained colon epithelial homeostasis by regulating the TNFα/NF-κB pathway(2024/05/27)
作者：Limei Peng, Yingpeng Shi, Jiacheng Deng
期刊：BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
DOI：10.1016/j.bbrc.2024.150176
影響因子 ：3.100
引用產(chǎn)品：PM150710
-
Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours(2024/03/19)
作者：Mengqi Deng, Ruiye Yang, Qi Sun
期刊：BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
影響因子 ：3.100
引用產(chǎn)品：PM150710
-
Astragaloside IV regulates circ_0001615 and miR-873-5p/LASP1 axis to suppress colorectal cancer cell progression(2024/01/04)
作者：Pengfei Kong, Xuemei Tang, Fang Liu
期刊：Chemical Biology & Drug Design
影響因子 ：3.000
引用產(chǎn)品：PM150710
-
microRNA-4429-5p suppresses the malignant development of colon cancer by targeting matrix metalloproteinase 16(2021/08/26)
作者：Wei Li,?Zhe Song,?Nan Jia
期刊：In Vitro Cellular & Developmental Biology-Animal
DOI：10.1007/s11626-021-00603-4
影響因子 ：2.723
引用產(chǎn)品：CL-0050 CL-0096 CL-0144 CL-0223 CL-0225 PM150710 PM150910 PM151010
-
Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer(2023/12/10)
作者：Chao Gao, Xiangqin Fan, Yanyan Liu
期刊：International Journal of General Medicine
影響因子 ：2.300
引用產(chǎn)品：PM150710
-
OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer(2023/08/29)
作者：Yu Zhong, Ouyang Ling
期刊：Discover Oncology
DOI：10.1007/s12672-023-00778-0
影響因子 ：2.200
引用產(chǎn)品：PM150710
-
Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3(2023/04/10)
作者：Xue Hu, Baoliang Guo, Tong Sun
期刊：Open Medicine
影響因子 ：2.100
引用產(chǎn)品：164210 164215 CL-0149 CL-0150 CL-0211 CL-0383 CL-0525 PB180120 PB180424 PM150140 PM150312 PM150710 PM151010
-
Novel artesunate-metformin conjugate inhibits bladder cancer cell growth associated with Clusterin/SREBP1/FASN signaling pathway.(2024/05/01)
作者：Peiyu Lin, Xiyue Yang, Linghui Wang
期刊：KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
DOI：10.4196/kjpp.2024.28.3.219
影響因子 ：2.000
引用產(chǎn)品：PM150710
-
The role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis(2023/01/13)
作者：Lang Cheng, Xiong Zou, Jiawei Wang
期刊：Frontiers in Surgery
DOI：10.3389/fsurg.2022.1117307
影響因子 ：1.800
-
Patient-derived bladder cancer organoid model to predict sensitivity and feasibility of tailored precision therapy(2023/07/21)
作者：Ying Jiang, Xun Sun, Xiaoyun Song
期刊：Current Urology
DOI：10.1097/CU9.0000000000000219
影響因子 ：1.600
引用產(chǎn)品：PM150710
-
CircSCNN1A inhibits the proliferation, migration and invasion of renal cell carcinoma cells by decreasing CLDN8 expression through miR-590-5p(2024/05/19)
作者：Tingting Guo, Wanjuan Xiong, Chong Liu
期刊：GENESIS
影響因子 ：1.500
引用產(chǎn)品：PM150710
-
PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/β-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib(2022/09/05)
作者：Xiaocui Zhang, Meige Sun, Yisheng Jiao
期刊：Oxidative Medicine and Cellular Longevity
影響因子 ：0.000
引用產(chǎn)品：164210 164210-50 CL-0079 CL-0178 PM150110 PM150710
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識別碼示意圖
